The relative importance of common and rare genetic variants in the development of hypertriglyceridemia

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 5, 2011, Pages 637-644

  Evans, David ^a   Aberle, Jens ^a   Beil, Frank Ulrich ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

hypertriglyceridemia; rare and common variants; resequencing

Indexed keywords

LIPID; TRIACYLGLYCEROL;

EPIGENETICS; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

DYSLIPIDEMIAS; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; HYPERTRIGLYCERIDEMIA;

EID: 79959235022     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.53     Document Type: Review

References (64)

1. Wallace RB, Anderson RA. Blood lipids, lipid-related measures, and the risk of atherosclerotic cardiovascular disease. Epidemiol. Rev. 9, 95-119 (1987)
2. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler. Thromb. 11, 2-14 (1991)
3. Holme I. Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis. Br. Heart J. 69, S42-S47 (1993) (Pubitemid 23035606)
4. Rao DC, Laskarzewski PM, Morrison JA et al. The Cincinnati Lipid Research Clinic family study: cultural and biological determinants of lipids and lipoprotein concentrations. Am. J. Hum. Genet. 34, 888-903 (1982) (Pubitemid 13093681)
5. Segal P, Rifkind BM, Schull WJ. Genetic factors in lipoprotein variation. Epidemiol. Rev. 4, 127-160 (1982)
6. Namboodiri KK, Kaplan EB, Heuch I et al. The collaborative Lipid Research Clinics family study: biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet. Epidemiol. 2, 227-254 (1985) (Pubitemid 15023349)
7. Heller DA, deFaire U, Pedersen NL, Dahlen G, McClean GE. Genetic and environmental influences on serum lipid levels in twins. N. Engl. J. Med. 328, 1150-1156 (1993) (Pubitemid 23105752)
8. Hegele RA. Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism. Am. J. Hum. Genet. 69, 1161-1177 (2001) (Pubitemid 33124198)
9. Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat. Rev. Genet. 10, 109-121 (2009)
10. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 40, 695-701 (2008) (Pubitemid 351748875)
11. Schork NJ, Murray SS, Frazer KA et al. Common vs. rare allele hypotheses for complex diseases. Curr. Opin. Genet. Dev. 19, 212-219 (2009)
12. Goldstein DB. Common genetic variation and human traits. N. Engl. J. Med. 360, 1696-1698 (2009).
13. Manolio TA, Collins FS, Cox NJ et al. Finding the missing heritability of complex diseases. Nature 461, 747-753 (2009)
14. Kathiresan S, Melander O, Guiducci C et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40(2), 189-197 (2008) (Pubitemid 351171402)
15. Willer CJ, Sanna S, Jackson AU et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40(2), 161-169 (2008) (Pubitemid 351171403)
16. Kooner JS, Chambers JC, Aguilar-Salinas CA et al. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat. Genet. 40(2), 149-151 (2008) (Pubitemid 351171393)
17. Aulchenko YS, Ripatti S, Lindqvist I et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 41(1), 47-55 (2009)
18. Kathiresan S, Willer CJ, Peloso G et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41(1), 56-65 (2009)
19. Chasman DI, Paré G, Zee RYL et al. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ. Cardiovasc. Genet. 1, 21-30 (2008)
20. Chasman DI, Paré G, Mora S et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet. 5, e1000730 (2009)
21. Waterworth DM, Ricketts SL, Song K et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 30, 2264-2276 (2010)
22. Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010)
23. Eichler EE, Flint J, Gibson G et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet. 11, 446-450 (2010)
24. Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat. Rev. Genet. 11, 415-425 (2010)
25. Kryukov GV, Pennacchio LA, Sunyaev SR. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am. J. Hum. Genet. 80, 727-739 (2007) (Pubitemid 46564409)
26. Wang H, Eckel RH. Lipoprotein lipase: from gene to obesity Am. J. Physiol. Endocrinol. Metab. 297, E271-E288 (2009)
27. Calandra S, Oliva CP, Tarugi P et al. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr. Opin. Lipdol. 17, 122-127 (2006)
28. Sagoo GS, Tatt I, Salanti G et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am. J. Epidemiol. 168, 1233-1246 (2008)
29. Hubacek JA. Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. Clin. Chem. Lab. Med. 43, 897-902 (2005) (Pubitemid 41461136)
30. Wang J, Ban MR, Kennedy BA et al. APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia. Nat. Rev. Gastroenterol. Hepatol. 5, 730-737 (2008)
31. Sarwar N, Sandhu MS, Ricketts SL et al.; Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 375, 1634-1639 (2010)
32. Nakayama K, Bayasgalan T, Yamanaka K et al. Large scale replication analysis of loci associated with lipid concentrations in a Japenese population. J. Med. Genet. 46, 370-374 (2009)
33. Weissglas-Volkov D, Aguilar-Salinas CA, Sinsheimer JS et al. Investigation of variants identified in Caucasian genome-wide association studies for plasma HDL cholesterol and triglyceride levels in Mexican dyslipidemic study samples. Circ. Cardiovasc. Genet. 3, 31-38 (2010)
34. Keebler ME, Sanders CL, Surti A et al. Association of blood lipids with common DNA sequence variants at 19 genetic loci in the multiethnic United States National Health and Nutrition Examination Survey III. Circ. Cardiovasc. Genet. 2, 238-243 (2009)
35. Kathiresan S, Melander O, Anevski D et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N. Engl. J. Med. 358(12), 1240-1249 (2008) (Pubitemid 351439225)
36. Lanktree MB, Anand SS, Yusuf S et al. Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample. J. Lipid Res. 50, 1487-1496 (2009)
37. Wang J, Cao H, Ban MR et al. Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650) Arterioscler. Thromb. Vasc. Biol. 27, 2450-2455 (2007) (Pubitemid 350203963)
38. Talmud PJ, Drenos F, Shah S et al. Gene-centric association signals for lipids and apolipoproteins identified via the human CVD BeadChip. Am. J. Hum. Genet. 85, 628-642 (2009)
39. Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, ApoC-II deficiency, and hepatic lipase deficiency. In:The Metabolic and Molecular Bases of Inherited Disease. 8th Edition. Scriver CR, Beaudet AL, Sly WS, Valle D (Eds)McGraw Hill, NY, USA, 2789-2816 (2001)
40. Talmud P. Rare APOA5 mutations-clinical consequences, metabolic and functional effects. Athereosclerosis 194, 287-292 (2007) (Pubitemid 47513112)
41. Johansen CT, Wang J, Lanktree MB et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat. Genet. 42, 684-687 (2010)
42. Evans D, Arzer J, Aberle J, Beil FU. Rare variants in the lipoprotein lipase gene are common in hypertriglyceridemia but rare in type III hyperlipidemia. Atherosclerosis 214(2), 386-390 (2010)
43. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake and regulation. J. Lipid Res. 43, 1997-2006 (2002) (Pubitemid 35471065)
44. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids and lipoporoteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99, 2901-2907 (1999) (Pubitemid 29258978)
45. Bruin T, Tuzgöl S, Mulder WJ et al. A compound heterozygote for lipoprotein lipase deficiency, Val69Leu and Gly188Glu: correlation between in vitro LPL activity and clinical expression. J. Lipid Res. 35, 438-445 (1994) (Pubitemid 24081857)
46. Sunyaev S, Ramensky V, Koch I et al. Prediction of deleterious human alleles. Hum. Mol. Genet. 10, 591-597 (2001) (Pubitemid 32229363)
47. Brunham LR, Singaraja RR, Pape TD et al. Accurate prediction of the functional significance of single-nucleotide polymorphisms and mutations in the ABCA1 gene. PLoS Gene 1, e83 (2005).
48. Evans D, Buchwald A, Beil FU. The single nucleotide polymorphism, -1131TC, in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J. Mol. Med. 81, 645-654 (2003) (Pubitemid 37357679)
49. Bosch JR, Grody WW. Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. J. Mol. Diagn. 10484-10492 (2008)
50. Metzker ML. Sequencing technologies - the next generation. Nat. Rev. Genet. 11, 31-46 (2010)
51. Wang T, Lin CY, Rohan TE, Ye K. Resequencing of pooled DNA for detecting disease associations with rare variants. Genet. Epidemiol. 34, 492-501 (2010)
52. Bansal V, Libiger O, Torkamanl A et al. Statistical analysis strategies for association studies involving rare variants Nat. Rev. Genet. 11, 773-785 (2010)
53. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In:The Metabolic and Molecular Bases of Inherited Disease (8th Edition) Scriver CR, Beaudet AL, Sly WS, Valle D (Eds)McGraw Hill, NY, USA, 2863-2913 (2001)
54. Kane JP, Havel RJ. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In:The Metabolic and Molecular Bases of Inherited Disease. (8th Edition) Scriver CR, Beaudet AL, Sly WS, Valle D (Eds)McGraw Hill, NY, USA, 2717-2752 (2001)
55. Kotowski IK, Pertsemlidis A, Luke A et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am. J. Hum. Genet. 3, 410-422 (2006) (Pubitemid 43291224)
56. Garcia CK, Wilund K, Arca M et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292, 1394-1398 (2001) (Pubitemid 32476229)
57. Edmondson A, Brown RJ, Kathiresan S et al. Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J. Clin. Invest. 119(4), 1042-1050 (2009)
58. Assmann G, von Eckardstein A, Brewer HB. Familial analphalipoproteinemia: Tangier disease. In:The Metabolic and Molecular Bases of Inherited Disease. (8th Edition) Scriver CR, Beaudet AL, Sly WS, Valle D (Eds)McGraw Hill, NY, USA, 2937-2960 (2001)
59. Santamarina-Fojo S, Hoeg JM, Assmann G, Brewer HB. Lecithin cholesterol acyltransferase deficiency and fish eye disease. In:The Metabolic and Molecular Bases of Inherited Disease. (8th Edition) Scriver CR, Beaudet AL, Sly WS, Valle D (Eds)McGraw Hill, NY, USA, 2817-2833 (2001)
60. Beigneux AP, Franssen R, Bensadoun A et al. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler. Thromb. Vasc. Biol. 29, 956-962 (2009)
61. Péterfy M, Ben-Zeev O, Mao HZ, et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat. Genet. 39, 1483-1487 (2007) (Pubitemid 350191343)
62. Romeo S, Yin W, Kozlitina J, et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Invest. 119, 70-79 (2009)
63. Romeo S, Pennacchio LA, Fu Y et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 39, 513-516 (2007) (Pubitemid 46514768)
64. Cohen JC, Kiss RS, Pertsemlidis A et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305, 869-872 (2004). (Pubitemid 39038422)